Fielmann Aktiengesellschaft (FIE) - Net Assets
Based on the latest financial reports, Fielmann Aktiengesellschaft (FIE) has net assets worth €972.00 Million EUR (≈ $1.14 Billion USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€2.39 Billion ≈ $2.79 Billion USD) and total liabilities (€1.42 Billion ≈ $1.66 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check FIE asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €972.00 Million |
| % of Total Assets | 40.71% |
| Annual Growth Rate | 5.88% |
| 5-Year Change | 9.18% |
| 10-Year Change | 36.74% |
| Growth Volatility | 5.78 |
Fielmann Aktiengesellschaft - Net Assets Trend (2002–2024)
This chart illustrates how Fielmann Aktiengesellschaft's net assets have evolved over time, based on quarterly financial data. Also explore how large is Fielmann Aktiengesellschaft's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Fielmann Aktiengesellschaft (2002–2024)
The table below shows the annual net assets of Fielmann Aktiengesellschaft from 2002 to 2024. For live valuation and market cap data, see market cap of Fielmann Aktiengesellschaft.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €913.14 Million ≈ $1.07 Billion |
-1.41% |
| 2023-12-31 | €926.16 Million ≈ $1.08 Billion |
+8.16% |
| 2022-12-31 | €856.30 Million ≈ $1.00 Billion |
-1.89% |
| 2021-12-31 | €872.79 Million ≈ $1.02 Billion |
+4.36% |
| 2020-12-31 | €836.36 Million ≈ $977.79 Million |
+15.10% |
| 2019-12-31 | €726.65 Million ≈ $849.53 Million |
+2.46% |
| 2018-12-31 | €709.22 Million ≈ $829.15 Million |
+2.04% |
| 2017-12-31 | €695.01 Million ≈ $812.54 Million |
+1.27% |
| 2016-12-31 | €686.26 Million ≈ $802.32 Million |
+2.77% |
| 2015-12-31 | €667.79 Million ≈ $780.72 Million |
+6.07% |
| 2014-12-31 | €629.60 Million ≈ $736.07 Million |
+5.91% |
| 2013-12-31 | €594.49 Million ≈ $695.02 Million |
+4.08% |
| 2012-12-31 | €571.15 Million ≈ $667.74 Million |
+3.61% |
| 2011-12-31 | €551.27 Million ≈ $644.49 Million |
+4.60% |
| 2010-12-31 | €527.01 Million ≈ $616.13 Million |
+5.89% |
| 2009-12-31 | €497.69 Million ≈ $581.85 Million |
+6.28% |
| 2008-12-31 | €468.29 Million ≈ $547.48 Million |
+13.58% |
| 2007-12-31 | €412.29 Million ≈ $482.01 Million |
+7.37% |
| 2006-12-31 | €383.98 Million ≈ $448.91 Million |
+7.71% |
| 2005-12-31 | €356.49 Million ≈ $416.77 Million |
+6.05% |
| 2004-12-31 | €336.14 Million ≈ $392.98 Million |
+3.04% |
| 2003-12-31 | €326.21 Million ≈ $381.38 Million |
+25.58% |
| 2002-12-31 | €259.77 Million ≈ $303.70 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Fielmann Aktiengesellschaft's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2494.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €681.05 Million | 75.75% |
| Common Stock | €84.00 Million | 9.34% |
| Other Comprehensive Income | €41.95 Million | 4.67% |
| Other Components | €92.13 Million | 10.25% |
| Total Equity | €899.13 Million | 100.00% |
Fielmann Aktiengesellschaft Competitors by Market Cap
The table below lists competitors of Fielmann Aktiengesellschaft ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Guangxi Guitang Group Co Ltd
SHE:000833
|
$3.72 Billion |
|
Kiler Holding A.S.
IS:KLRHO
|
$3.72 Billion |
|
Assured Guaranty Ltd
NYSE:AGO
|
$3.73 Billion |
|
Monday.Com Ltd
NASDAQ:MNDY
|
$3.73 Billion |
|
Eastern Air Logistics Co Ltd
SHG:601156
|
$3.72 Billion |
|
Howard Hughes Holdings Inc.
NYSE:HHH
|
$3.72 Billion |
|
Shanghai V-Test Semiconductor Tech Co. Ltd. A
SHG:688372
|
$3.72 Billion |
|
Xiangcai Co Ltd
SHG:600095
|
$3.72 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Fielmann Aktiengesellschaft's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 867,654,000 to 899,131,000, a change of 31,477,000 (3.6%).
- Net income of 152,108,000 contributed positively to equity growth.
- Dividend payments of 83,971,000 reduced retained earnings.
- Share repurchases of 238,000 reduced equity.
- Other comprehensive income increased equity by 5,402,999.
- Other factors decreased equity by 41,824,999.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €152.11 Million | +16.92% |
| Dividends Paid | €83.97 Million | -9.34% |
| Share Repurchases | €238.00K | -0.03% |
| Other Comprehensive Income | €5.40 Million | +0.6% |
| Other Changes | €-41.82 Million | -4.65% |
| Total Change | €- | 3.63% |
Book Value vs Market Value Analysis
This analysis compares Fielmann Aktiengesellschaft's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.97x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 13.81x to 3.97x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2002-12-31 | €3.08 | €42.50 | x |
| 2003-12-31 | €3.87 | €42.50 | x |
| 2004-12-31 | €3.99 | €42.50 | x |
| 2005-12-31 | €4.24 | €42.50 | x |
| 2006-12-31 | €4.56 | €42.50 | x |
| 2007-12-31 | €4.91 | €42.50 | x |
| 2008-12-31 | €5.57 | €42.50 | x |
| 2009-12-31 | €5.92 | €42.50 | x |
| 2010-12-31 | €6.28 | €42.50 | x |
| 2011-12-31 | €6.56 | €42.50 | x |
| 2012-12-31 | €6.80 | €42.50 | x |
| 2013-12-31 | €7.08 | €42.50 | x |
| 2014-12-31 | €7.49 | €42.50 | x |
| 2015-12-31 | €7.95 | €42.50 | x |
| 2016-12-31 | €8.17 | €42.50 | x |
| 2017-12-31 | €8.27 | €42.50 | x |
| 2018-12-31 | €8.44 | €42.50 | x |
| 2019-12-31 | €8.60 | €42.50 | x |
| 2020-12-31 | €9.28 | €42.50 | x |
| 2021-12-31 | €9.76 | €42.50 | x |
| 2022-12-31 | €9.57 | €42.50 | x |
| 2023-12-31 | €10.33 | €42.50 | x |
| 2024-12-31 | €10.71 | €42.50 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Fielmann Aktiengesellschaft utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 16.92%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.72%
- • Asset Turnover: 0.96x
- • Equity Multiplier: 2.63x
- Recent ROE (16.92%) is below the historical average (20.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2002 | 17.39% | 6.83% | 1.73x | 1.47x | €19.10 Million |
| 2003 | 21.59% | 8.54% | 1.53x | 1.65x | €37.66 Million |
| 2004 | 13.23% | 6.85% | 1.45x | 1.33x | €10.81 Million |
| 2005 | 15.44% | 7.51% | 1.46x | 1.41x | €19.40 Million |
| 2006 | 17.99% | 8.71% | 1.49x | 1.39x | €30.66 Million |
| 2007 | 19.90% | 9.78% | 1.44x | 1.41x | €40.82 Million |
| 2008 | 23.63% | 12.26% | 1.38x | 1.40x | €63.82 Million |
| 2009 | 22.98% | 12.01% | 1.44x | 1.33x | €64.58 Million |
| 2010 | 22.91% | 12.15% | 1.44x | 1.31x | €68.09 Million |
| 2011 | 22.09% | 11.56% | 1.45x | 1.32x | €66.62 Million |
| 2012 | 22.13% | 11.41% | 1.47x | 1.32x | €69.26 Million |
| 2013 | 23.22% | 11.93% | 1.45x | 1.35x | €78.60 Million |
| 2014 | 25.00% | 12.83% | 1.46x | 1.33x | €94.38 Million |
| 2015 | 24.80% | 12.73% | 1.46x | 1.33x | €98.78 Million |
| 2016 | 24.24% | 12.44% | 1.46x | 1.33x | €97.71 Million |
| 2017 | 24.13% | 12.09% | 1.50x | 1.33x | €98.15 Million |
| 2018 | 23.82% | 11.83% | 1.51x | 1.33x | €97.99 Million |
| 2019 | 23.83% | 11.32% | 1.11x | 1.89x | €99.94 Million |
| 2020 | 14.94% | 8.15% | 0.86x | 2.14x | €38.49 Million |
| 2021 | 16.69% | 8.16% | 0.97x | 2.12x | €54.87 Million |
| 2022 | 12.89% | 5.89% | 1.00x | 2.20x | €23.24 Million |
| 2023 | 14.71% | 6.48% | 0.99x | 2.29x | €40.88 Million |
| 2024 | 16.92% | 6.72% | 0.96x | 2.63x | €62.19 Million |
Industry Comparison
This section compares Fielmann Aktiengesellschaft's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $5,621,340,699
- Average return on equity (ROE) among peers: -86.39%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Fielmann Aktiengesellschaft (FIE) | €972.00 Million | 17.39% | 1.46x | $3.72 Billion |
| SCHOTT Pharma AG & Co. KGaA (1SXP) | $709.04 Million | 17.68% | 0.69x | $2.39 Billion |
| RENAU.UNSP.ARD 1/5 EO-20 (56S0) | $2.51 Billion | 34.85% | 1.01x | $16.46 Billion |
| MEDIMI AB AK (79T) | $332.69K | -959.52% | 4.12x | $427.04K |
| TEVANO SYSTEMS HLDGS INC. (7RBA) | $-1.31 Million | 0.00% | 0.00x | $210.67K |
| STEVANATO GROUP SPA O.N. (87N) | $841.66 Million | 15.96% | 0.69x | $831.06 Million |
| Carl Zeiss Meditec AG (AFX) | $797.45 Million | 7.81% | 0.43x | $2.23 Billion |
| CARL ZEISS MEDITEC ADR 1 (AFXA) | $2.06 Billion | 8.69% | 0.65x | $2.14 Billion |
| Bio-gate AG (BIG1) | $1.55 Million | -51.89% | 1.13x | $5.32 Million |
| COLOPLAST SP.ADR 1/10 DK1 (CBH) | $8.29 Billion | 56.75% | 3.52x | $12.73 Billion |
| ESSILORLUXOTTICA 1/2/O.N. (ESLC) | $41.00 Billion | 5.75% | 0.57x | $93.24 Billion |
About Fielmann Aktiengesellschaft
Fielmann Group AG engages in vision care and audiology business in Germany, Switzerland, Austria, Spain, North America, and internationally. The company manufactures and sells visual aids mainly glasses, eyewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems and its accessories, as well as personal protective equipment. It offers its products under the fielmann, Optik… Read more